Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Top Cited Papers
- 1 January 2011
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 24 (1) , 29-70
- https://doi.org/10.1128/cmr.00036-10
Abstract
SUMMARY: A select group of microorganisms inhabit the airways of individuals with cystic fibrosis. Once established within the pulmonary environment in these patients, many of these microbes adapt by altering aspects of their structure and physiology. Some of these microbes and adaptations are associated with more rapid deterioration in lung function and overall clinical status, whereas others appear to have little effect. Here we review current evidence supporting or refuting a role for the different microbes and their adaptations in contributing to poor clinical outcomes in cystic fibrosis.Keywords
This publication has 661 references indexed in Scilit:
- Pulmonary exacerbations in cystic fibrosis with negative bacterial culturesPediatric Pulmonology, 2010
- Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunityInternational Journal of Medical Microbiology, 2007
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosaThe Journal of Pediatrics, 1990
- Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosisThe Journal of Pediatrics, 1988
- Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosisThe Journal of Pediatrics, 1988
- Clinical features as predictors of functional status in children with cystic fibrosisThe Journal of Pediatrics, 1986
- Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcomeThe Journal of Pediatrics, 1985
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosisThe Journal of Pediatrics, 1980